secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001628280-24-027680
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals annual meeting elects directors, ratifies auditor, approves say-on-pay
--------------------------------------------------------------------------------

- Stockholders elected David McGirr, Paula Ragan, and Michael S. Wzyga as directors for three-year terms.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for FY 2024 passed with 129,116,244 for, 620,394 against.
- Non-binding say-on-pay vote approved with 89,159,259 for, 4,443,024 against, and 36,561,395 broker non-votes.
- All three proposals received requisite majority support; no other matters were submitted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828024027680/0001628280-24-027680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828024027680/xfor-20240610.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-027680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer